News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Additional Central Asian state-owned infrastructure firms are exploring Hong Kong listings, expanding the city's Belt and Road capital links.
  • Officials gave no names or timing for the potential Hong Kong listings.
  • OPEC+ is expected to keep October oil output policy unchanged while members review quotas and capacity.
  • Export disruptions through the Strait of Hormuz linked to the Iran war have left OPEC+ producing below targets.
  • Analysts recommend buying SSR Mining, citing zero debt, roughly $7 cash per share and strong recent free cash flow.

Latest Articles

Diversified Announces Accretive Acquisition of Birch

Diversified Announces Accretive Acquisition of Birch

Diversified Energy Company (NYSE: DEC) has entered into definitive agreements to acquire Birch Permian Holdings for approximately $1.8 billion, marking its largest acquisition ever. The deal enhances Diversified's position as a major operator in the Permian Basin by increasing production by about 35% and adjusted EBITDA by approximately 55%. The ac…

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

Revolution Medicines announced that the New England Journal of Medicine has published Phase 1/2 clinical trial data on their drug RASONQUE (daraxonrasib) in treating RAS mutant non-small cell lung cancer (NSCLC). The study showed promising objective response and disease control rates with a manageable safety profile. The data supports the ongoing P…

BioRestorative Therapies Announces Reverse Stock Split

BioRestorative Therapies Announces Reverse Stock Split

BioRestorative Therapies, Inc. announced a 1-for-20 reverse stock split effective September 7, 2026, aiming to regain compliance with Nasdaq's $1.00 minimum bid price listing rule. The stock will begin trading on a reverse-split basis on September 8, 2026, maintaining current shareholder ownership percentages. The company is a clinical-stage regene…

Capital Southwest Increases Corporate Credit Facility to $595 million and Extends Maturity to September 2031

Capital Southwest Increases Corporate Credit Facility to $595 million and Extends Maturity to September 2031

Capital Southwest Corporation announced an amendment to its senior secured corporate credit facility, increasing borrowing capacity from $510 million to $595 million with an option to expand to $1 billion. The amendment reduces interest margins, lowers unused commitment fees, removes the SOFR adjustment, and extends the maturity to September 2031. …

Hershey Elevates Longtime Finance Executive Dave Hulays to CFO

Hershey Elevates Longtime Finance Executive Dave Hulays to CFO

Sept 2 - Hershey has appointed Dave Hulays as chief financial officer, promoting a seasoned insider to the role with immediate effect. Hulays, 54, joined the company in 2012 and has held progressively broader finance responsibilities across Canada, the United States and international operations. The leadership change comes as the maker of Reese's r…

Archimedes Tech SPAC Partners II Co. Announces Filing of Third Amendment to Registration Statement on Form S-4 with the SEC

Archimedes Tech SPAC Partners II Co. Announces Filing of Third Amendment to Registration Statement on Form S-4 with the SEC

Archimedes Tech SPAC Partners II Co. (ATII), a Nasdaq-listed special purpose acquisition company (SPAC), announced the filing of the third amendment to its registration statement on Form S-4 with the SEC related to its proposed business combination with Forge Nano, Inc. Forge Nano specializes in advanced atomic layer deposition technology critical …

Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Third Quarter Common Stock Distribution of $0.1503 Per Share

Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Third Quarter Common Stock Distribution of $0.1503 Per Share

Sprott Focus Trust, Inc. has declared a quarterly distribution of $0.1503 per share on its Common Stock to be paid on September 29, 2026. The distribution follows the Fund's policy targeting an annualized 6% payout based on the rolling average NAV. The distribution can be taken in cash or reinvested in additional shares, and the Fund reported stron…

RoboStrategy, Inc. Updates Net Asset Value as of August 31, 2026

RoboStrategy, Inc. Updates Net Asset Value as of August 31, 2026

RoboStrategy, Inc., a Nasdaq-listed closed-end fund focused on robotics and physical AI private companies, announced its net asset value (NAV) per share rose to $11.35 as of August 31, 2026, representing a 0.27% increase month-over-month. The fund invests in leading innovators in robotics and autonomous systems to bridge public market access to pri…

Fort Technology Grants Restricted Share Units

Fort Technology Grants Restricted Share Units

Fort Technology Inc. has granted 102,857 restricted share units (RSUs) under its approved Omnibus Equity Incentive Plan, which includes allocations to an officer and consultants. The RSUs vest over a scheduled timeline and are subject to TSX Venture Exchange policies. Fort Technology, specializing in consumer products for pest control and remedial …

LyondellBasell: A Cash-Flow Recovery the Market Is Underweight

LyondellBasell: A Cash-Flow Recovery the Market Is Underweight

LyondellBasell (LYB) looks like a high-conviction swing trade. The stock is trading near $66.59 while the business is generating meaningful free cash flow and sits at an attractive EV/EBITDA multiple. We lay out an entry at $66.59, a stop at $60.00 and a target of $77.00, driven by improving polymer markets, durable FCF and a recovering EBITDA prof…